Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kristine N Wright"'
Autor:
Kathy A. Aldern, Douglas D. Richman, Ganesh D. Kini, James R. Beadle, Michael F. Gardner, Karl Y. Hostetler, Kristine N. Wright
Publikováno v:
Antiviral Chemistry and Chemotherapy. 9:33-40
In a previous study, we reported that 1- O-octadecyl- sn-glycero-3-foscarnet (ODG-PFA) was 40 to 93 times more potent than free foscarnet (PFA) in human cytomegalovirus (HCMV)-, herpes simplex virus type 1 (HSV-1)- and human immunodeficiency virus ty
Autor:
Kristine N. Wright, Brent A. Korba, James R. Beadle, Ganesh D. Kini, Michael F. Gardner, Karl Y. Hostetler, Tong-Hau Wu
Publikováno v:
Biochemical Pharmacology. 53:1815-1822
Acyclovir (ACV) triphosphate and azidothymidine (AZT) triphosphate inhibit the DNA polymerase of human hepatitis B virus (HBV) by 50% at submicromolar concentrations, but no effects of ACV or AZT treatment have been noted on the clinical manifestatio
Autor:
Ganesh D. Kini, Kathy A. Aldern, Kristine N. Wright, Rachel J. Rybak, Earl R. Kern, Michael F. Gardner, Karl Y. Hostetler, James R. Beadle
Publikováno v:
ChemInform. 31
We synthesized, 1-O-hexadecylpropanediol-3–P-acyclovir, an orally bioavailable lipid prodrug of acyclovir and evaluated it for in vitro and in vivo activity against herpes simplex virus infections. Although 1-O-hexadecylpropanediol-3–P-acyclovir
Purpose To determine the effect of molecular size on the drainage route of dextrans injected into the rat anterior chamber (AC). Methods Anesthetized adult rats received monocular AC injections of a mixture of 3-kDa dextran-cascade blue, 40-kDa dextr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf43f08b8150bdb52399b38f7ac9537
https://europepmc.org/articles/PMC5672831/
https://europepmc.org/articles/PMC5672831/
Autor:
Michael F. Gardner, Karl Y. Hostetler, Kristine N. Wright, James R. Beadle, Earl R. Kern, Ganesh D. Kini, Kathy A. Aldern, Rachel J. Rybak
Publikováno v:
Nucleosides, nucleotidesnucleic acids. 19(1-2)
We synthesized, 1-O-hexadecylpropanediol-3–P-acyclovir, an orally bioavailable lipid prodrug of acyclovir and evaluated it for in vitro and in vivo activity against herpes simplex virus infections. Although 1-O-hexadecylpropanediol-3–P-acyclovir